InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Strickland d Gordon. Director active across 2 companies, notably NeuroBo Pharmaceuticals, Inc.. Cumulatively, 3 reports have been recorded. Activity tracked since 27 July 2023. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations